Earlier Detection. Better Health.
Joined August 2016
- Tweets 151
- Following 59
- Followers 171
- Likes 92
79 Photos and videos
Jun 11
"Metastatic disease evolves over time. Molecular profiling needs to evolve with it."
Dr. Shane Dormady shares a case on using liquid biopsy at progression to find a critical PIK3CA mutation, leading to targeted therapy & a complete response.
Full video: lucence.com/patient-stories/…
1
1
5
Jun 10
A clear scan does not always mean no cancer remains.
MRD reads tumor-derived signal in blood after treatment, often through ctDNA, below what imaging can see.
One result is a moment. Serial testing is a pattern.
Read the full article here: lucence.com/clinical-insight…
2
2
14
Jun 9
We’re honored to welcome Dr. Shane Dormady, Medical Director of El Camino Health Cancer Center, to the Lucence Medical Advisory Board!
His expertise in oncology and patient-centered care will help advance precision diagnostics and expand access to actionable insights worldwide.
8
Jun 3
DNA looks for the breakpoint.
RNA reads the expressed fusion.
For gene fusions, that difference matters.
ctDNA remains essential, but ctRNA can reveal fusion signals DNA-only testing may miss.
Read more: lucence.com/clinical-insight…
1
6
Jun 2
A patient smoked for years. Standard advice wasn't enough.
After learning about clonal hematopoiesis result, significant lifestyle changes were made.
Clonal hematopoiesis is linked to increased risks of heart disease, stroke, and leukemia.
Full video: lucence.com/patient-stories/…
1
1
16
May 28
Cancer and CVD are often detected only after biological changes have progressed.
Advances in molecular testing expand how physicians study blood DNA/RNA, enabling earlier, more informed assessment.
In this video, CEO Dr Tan Min-Han shares impact across oncology, CVD and ageing.
1
9
May 26
When cancer spreads to the brain, blood tests may not show the full picture.
Behind the blood-brain barrier, key signals can be missed by standard blood testing.
Cerebrospinal fluid analysis is opening a new molecular window into CNS cancers.
Read more: lucence.com/clinical-insight…
1
31
May 21
In this inaugural piece from Lucence's new Clinical Insights series, we explore a growing challenge in cancer prevention: identifying cancers earlier where screening pathways do not exist, and the emerging role of liquid biopsy and MCED.
Full article: lucence.com/clinical-insight…
1
2
25
19 Dec 2025
Dr. Gilberto Lopes, Chief of the Division of Medical Oncology at the University of Miami, explores how liquid biopsy — combining ctDNA and ctRNA analysis — supports personalized treatment planning.
Full video: lnkd.in/g4t_QhtH
1
840
12 Jan 2025
We're honored to collaborate with Mayo Clinic Laboratories to expand liquid biopsy access to more cancer patients.
10 Jan 2025
Mayo Clinic Laboratories and @LucenceHealth are collaborating to expand access to advanced cancer diagnostics. With the LiquidHALLMARK® liquid biopsy, we’re delivering actionable genomic insights to support precision medicine & drive better outcomes.
bit.ly/3BSzsNn
2
239
28 Feb 2024
We're pleased to announce that our LiquidHALLMARK assay has been granted Medicare coverage for all types of advanced solid tumors.
Grateful for this milestone that allows us to contribute to more patient care!
lucence.com/lucencenews/luce…
1
1
2
523
24 Nov 2023
We were extremely honored to share our story with Singapore Prime Minister @leehsienloong during his #APEC2023 visit to the Bay Area.
It's been a 6-year journey to securing US Medicare coverage for our #liquidbiopsy tech to help US patients!
Photo credits: Enterprise Singapore
2
384
26 May 2023
Read 5 of our co-authored #ASCO23 abstracts here on multi-cancer early detection and ctDNA/ctRNA : lnkd.in/gNhqERfk
1
1
1,344
Lucence retweeted
26 May 2023
Besides the regular @ASCO #ASCO23 program, there are a number of interesting sponsored presentations.
Join me for dinner & discussion about #ctRNA being a game changer for #lungcancer detection and treatment selection #liquidbiopsy.
June 3 - 6:30pm CT, hosted by @lucencehealth bit.ly/lucence-asco23-dinner
@SylvesterCancer @ChristianRolfo @JackWestMD @n8pennell @NarjustFlorezMD @SamuelKareffMD @PriscilaBCMD @Latinamd @MudadRaja
1
10
76
7,676
10 May 2023
Our sincerest thanks to Singapore Deputy Prime Minister Heng Swee Keat for gracing the launch of LucenceINSIGHT™ at our US headquarters.
Press Release: lucence.com/lucencenews/luce…
#NoPatientLeftBehind
2
6
488
22 Feb 2023
We're pleased to announce that our LiquidHALLMARK assay has been granted Medicare coverage for lung cancer.
Deeply grateful for this opportunity to contribute to more patient care!
lucence.com/lucencenews/luce…
2
3
7
1,663
26 Jan 2023
So glad to be presenting research at the 1st AACR Special Conference for Acute Myeloid Leukemia and Myelodysplastic Syndrome in Austin, Texas.
See you there!
1
1
355
Lucence retweeted
15 Jan 2023
@YawBediako_ Founder and CEO Yemaachi and among @NewAfricanMag's 100 Most Influential Africans, is on a mission to fix unequal healthcare for patients with African ancestry. Such a moment for this genomics partnership born out of our work together at @VAInstitute !
3
6
2,587
10 Jan 2023
Interested in how #mirrorbarcodes and #ctRNA can enable multi-cancer early detection?
We're committed to this mission and excited to share.
Our CEO @minhantan and CFO Vee Kiet Chan are looking forward to chat at #JPM2023!
228
30 Dec 2022
Year in Review
We're thankful to help patients across the United States, Asia and Africa.
And here's our deepest gratitude to all of you who make Lucence who we are.
Thank you to our partners, investors, healthcare providers and most of all, to our patients, for trusting us!
1
2
244